Alpha-Methyldopa in Arterial Hypertension
- 24 April 2009
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 174 (1) , 53-67
- https://doi.org/10.1111/j.0954-6820.1963.tb07891.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Another Hypotensive Agent--MethyldopaBMJ, 1962
- Die Bedeutung des α-Methyldopa für die Behandlung der chronischen HypertonieDeutsche Medizinische Wochenschrift (1946), 1962
- METHYLDOPA IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1962
- METHYLDOPA IN HYPERTENSION CLINICAL AND PHARMACOLOGICAL STUDIESThe Lancet, 1962
- Effect of Alpha-Methyl DOPA in Severe and Malignant HypertensionPublished by American Medical Association (AMA) ,1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- Hemodynamic Effects of Methyldopa (Aldomet®) at Rest and during Exercise in Patients with Arterial HypertensionActa Medica Scandinavica, 1962
- In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl MetatyrosineActa Physiologica Scandinavica, 1962
- Actions of the Decarboxylase Inhibitor, α-Methyl-3,4-dihydroxyphenylalanine, in the DogNature, 1960
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960